[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial on the efficacy and safety of Lanjin oral liquid in the treatment of wind-heat syndrome of cold (acute upper respiratory tract infection)
1. 根据疾病的临床痊愈率评价蓝金口服液治疗感冒(急性上呼吸道感染)风热证的有效性。
2. 评估蓝金口服液治疗感冒(急性上呼吸道感染)风热证在缩短病程、改善其他指标方面的有效性。
3. 观察蓝金口服液临床应用的安全性。
[Translation] 1. To evaluate the effectiveness of Blue Gold Oral Liquid in treating wind-heat syndrome of cold (acute upper respiratory tract infection) based on the clinical cure rate of the disease.
2. To evaluate the effectiveness of Blue Gold Oral Liquid in treating wind-heat syndrome of cold (acute upper respiratory tract infection) in shortening the course of disease and improving other indicators.
3. To observe the safety of Blue Gold Oral Liquid in clinical application.